Other Assets, Noncurrent in USD of Fulcrum Therapeutics, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Fulcrum Therapeutics, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2018 to Q3 2025.
  • Fulcrum Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $9K, a 88.2% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Fulcrum Therapeutics, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $9K -$67K -88.2% 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $12K -$1.98M -99.4% 30 Jun 2025 10-Q 29 Jul 2025
Q1 2025 $10K -$1.98M -99.5% 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $10K -$2M -99.5% 31 Dec 2024 10-Q 29 Oct 2025
Q3 2024 $76K -$1.91M -96.2% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $1.99M -$6K -0.3% 30 Jun 2024 10-Q 31 Jul 2024
Q1 2024 $1.99M -$43K -2.12% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $2.01M -$94K -4.47% 31 Dec 2023 10-K 25 Feb 2025
Q3 2023 $1.99M -$108K -5.15% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $2M -$111K -5.27% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $2.03M +$1.22M +149% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $2.11M +$1.56M +288% 31 Dec 2022 10-K 27 Feb 2024
Q3 2022 $2.1M +$1.58M +304% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $2.11M +$1.58M +297% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $816K +$253K +44.9% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $542K -$36K -6.23% 31 Dec 2021 10-K/A 26 Jun 2023
Q3 2021 $519K -$97K -15.7% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $531K +$455K +599% 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 $563K +$484K +613% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $578K +$519K +880% 31 Dec 2020 10-K/A 26 Jun 2023
Q3 2020 $616K +$557K +944% 30 Sep 2020 10-Q 10 Nov 2020
Q2 2020 $76K -$548K -87.8% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 $79K 31 Mar 2020 10-Q 13 May 2020
Q4 2019 $59K +$21K +55.3% 31 Dec 2019 10-K/A 23 Jun 2023
Q3 2019 $59K 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $624K 30 Jun 2019 10-Q 26 Aug 2019
Q4 2018 $38K 31 Dec 2018 10-K 05 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.